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Abstract
Recent advances in culture-free microbiological techniques bring new understanding of the
role of intestinal microbiota in heath and performance. Intestinal microbial communities in
chickens assume a near-stable state within the week which leaves a very small window for
permanent microbiota remodelling. It is the first colonisers that determine the fate of micro-
bial community in humans and birds alike, and after the microbiota has matured there are
very small odds for permanent modification as stable community resists change. In this
study we inoculated broiler chicks immediately post hatch, with 3 species of Lactobacillus,
identified by sequencing of 16S rRNA and pheS genes as L. ingluviei, L. agilis and L. reuteri.
The strains were isolated from the gut of healthy chickens as reproducibly persistent Lacto-
bacillus strains among multiple flocks. Birds inoculated with the probiotic mix reached signifi-
cantly higher weight by 28 days of age. Although each strain was able to colonise when
administered alone, administering the probiotic mix at-hatch resulted in colonisation by only
L. ingluviei. High initial abundance of L. ingluviei was slowly reducing, however, the effects
of at-hatch administration of the Lactobacillus mix on modifying microbiota development
and structure remained persistent. There was a tendency of promotion of beneficial and
reduction in pathogenic taxa in the probiotic administered group.
Introduction
The gastrointestinal tract (GIT) of broilers plays an important role in their health and perfor-
mance [1]. GIT health is dependent upon complex interactions between diet, host bacterial
community (microbiota) and intestinal functioning [2]. When gut health is compromised
digestion and nutrient absorption are affected resulting in poor feed utilisation and suscepti-
bility to disease [3]. Studies of broilers fed probiotics have demonstrated improved weight
gain, and improved feed conversion ratios [4–8].
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Recent studies have powerfully linked GIT microbiota to health in animals including
chicken (reviewed in Stanley et al. [1]) and humans [9–11]. Other studies confirmed a link
between GIT microbiota and obesity [12], suggesting that the manipulation of intestinal
microbiota could be used to manipulate weight gain. Interactions between host and microbiota
are, however, complex, and can have a positive or negative effect [13].
Microbes that confer health and performance benefits are called probiotics [14]. The mech-
anisms of probiotic action include: scavenging free-radicals [15], producing bacteriocins [16],
influencing intestinal mucin gene expression [17], exclusion and inhibition of pathogens [18–
20], and virulence attenuation [21]. Fuller [22] summarized the benefits as improved feed con-
version rates, increased growth rates, greater disease resistance, improved digestion and
absorption of nutrients, improved carcass quality and reduction of zoonotic bacteria. Sanders
[23] reported a reduction in lactose intolerance and modulated immune system functions.
According to Conway [24] and Dunne et al. [25], probiotic strains should be of host origin,
non-pathogenic, suitable for manufacturing and delivery, capable of adhering to gut mucosa,
modulate immune function, improve intestinal function and growth and produce non-toxic
metabolites. The most reported health benefits of probiotics have been improvements in diges-
tive health and function [26]. The GIT microbiota aids in digestion and absorption of nutrients
by catabolizing substrates [27].
Probiotics are a promising alternative to antibiotics because they can control pathogens [28,
29]. Probiotics can competitively exclude pathogens in the intestine by successfully competing
for nutrients, adhering to the mucosa, modulating a favorable immune response, secreting
bacteriocins, creating a favorable environment (eg. lowering pH by secreting lactic and acetic
acid), and regulating colonocyte gene expression [30–32]. Bacteria that lower the pH of the gut
by secreting lactic acid (eg. Lactobacillus) are considered suitable candidate [33] for pathogen
control. Studies have shown the efficacy of certain Lactobacillus strains in suppressing or
excluding Salmonella spp., Escherichia coli, Enterococcus spp., Clostridium perfringens and
Campylobacter spp.[34, 35].
Here we present a study aimed at manipulating gut microbiota of chickens at-hatch, by pro-
viding an inoculum of carefully selected beneficial strains, isolated as able to persistently colo-
nise poultry. At hatch, the initial inoculum shapes the gut microbiota of chickens for life. The
first bacteria to enter their intestine, are able to adhere to epithelial cells without competition,
rapidly establish, proliferate and set the intestinal environment in terms of metabolite profiles
and pH, to best suit their own needs. The first bacterial settlers have the highest influence on
the development of intestinal microbiota and subsequent health and productivity of the bird
[1, 36]. The development of GIT microbiota in broilers begins immediately post-hatch and is
highly variable during early development [36–38]. The diversity and distribution of bacterial
species, that make up the GIT microbiota, fluctuates post-hatch and becomes well established
as fast as by day 3 [38] or, in a different study, by day 11 [39]. After establishment period,
microbiota continues to steadily mature at a slower rate [37]. Not only is the diversity and dis-
tribution of the microbiota age dependant, it is also host dependent [40]. Maturity assumes sta-
ble microbiota with the ability to resist change, even as severe as antibiotic administration
[41], thus we propose that probiotics administered after day 3 will find that the gut is already
colonized with near-established community and that only post-hatch administration of probi-
otics offers the most likely opportunity to achieve permanent colonisation in birds and influ-
ence the development of microbiota and thus influence bacterial profile throughout the bird’s
life. To test this hypothesis we performed a controlled experiment using culture-free sequenc-
ing methodology to observe total bacterial community and inspect the colonisation and suc-
cess of probiotic’s persistence between at hatch administered probiotic treatment and a sterile
PBS inoculated control.
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Materials and methods
Inoculum preparation
Lactobacillus strains were derived from caecal samples collected from birds used in three
experiments described by Stanley et al. [42]. Briefly, 3 identical broiler trials (each with n = 96)
were performed within 5 months in fully environmentally controlled animal facility. Birds
were placed in individual metabolic cages from day 15 to day 25 for reliable individual perfor-
mance indicators. The caecal samples had been stored at -80˚C to ensure freeze-thaw resis-
tance of cultured isolates. Samples from healthy birds with the best growth performance were
used. The caecal content samples were diluted in MRS broth and plated out onto MRS agar
plates. Visually distinct colonies were picked and screened using 16S rRNA gene sequencing.
The derived 16S sequences were compared to the NCBI 16S Microbial database to determine
the probable genus designation of each isolate and compare isolate to isolate similarity. After
this stage the ability to colonise was confirmed in vivo and successful colonisers were further
identified via Sanger sequencing of near full length 16S amplicons and the species assignment
confirmed by sequencing the pheS gene of each isolate. Complete and reliable species identifi-
cation requires a combination of techniques including DNA hybridisation, sequencing of
marker genes, restriction enzyme, sugar utilisation and metabolite profiling, we thus do not
claim definite but rather putative species assignment. We aimed to use 3 distinct Lactobacillus
species, isolated from chicken, which we found abundant and persistent in birds from flocks
with extremely different microbiota [36] to investigate whether very early colonising with
these chicken-derived Lactobacillus strains would provide permanent microbiota modifica-
tion. The number of bacterial cells of the 3 strains was equalised via pooling of 3 separate
inoculums of equal optical density (OD600) using freshly plate-grown cells resuspended in
PBS.
At-hatch administration of probiotic mix
Fertilised eggs (Ross 308) were obtained from Bonds hatchery in Toowoomba, Queensland.
The eggs were not cleaned or fumigated. The incubator (YBS-FD-440) was cleaned but not
fumigated. Hatchlings (n = 11 birds per treatment) were inoculated with either 1ml of sterile
PBS or 1ml of inoculum mixture in PBS at 2 hours post-hatch, allowing the birds to dry in the
incubator. All birds used in the study hatched within 36 hours. The inoculum mixture con-
tained equal amounts of freshly plate-grown strains provisionally identified as L. ingluviei, L.
agilis and L. reuteri. The two groups of birds were then placed in two separate pens on wood
shavings in a temperature controlled room. Each pen was 1.2m x 1.2m. The temperature in the
room was set as per breed recommendations and 14 hours light, 10 hours dark schedule was
used after removing brooding lamps at 5 days of age. Feed used was antibiotic and anticocci-
dials free chicken starter crumbles (Blue Ribbon Stockfeed, Rockhampton, Queensland). Indi-
vidual birds were weighed daily, and pen feed intake also measured daily, for 28 days. Excreta
samples were taken for microbiota analysis at 14 days, and before slaughtering of the birds at
28 days of age. The samples were collected by placing wide wire confining divider into the pen,
separating one bird from others without handling or removing the bird from the pen and wait-
ing for the bird to pass the fresh excreta. Care was taken that fresh excreta taken as a sample
was free of any caecal matter by visual observation. In addition, caecal contents and ileal
mucosa scrapings were collected at 28 days and prepared for microbiota analysis.
DNA was extracted using Bioline ISOLATE Faecal DNA Kit (#BIO-52038) according to the
manufacturer’s instructions and 16S variable regions V3-V4 were amplified. DNA was ampli-
fied using Q5 DNA polymerase (New England Biolabs). Sequencing was performed on an
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Illumina MiSeq system (2 x 300 bp) using the dual-indexing, variable spacer, method detailed
by Fadrosh et al. [43]. The quality filtered sequences were analysed in QIIME 1.9.1 software
[44] using QIIME default parameters unless stated otherwise. OTUs were picked using
UCLUST algorithm (Edgar 2010) at 97% sequence identity and inspected for chimeric
sequences using Pintail [45] and taxonomy assigned with GreenGenes database [46]. Addi-
tional taxonomic assignments were done using blastn against the NCBI 16S database. Data
were analysed and visualised using Calypso [47]. The OTU table was filtered to remove low
abundance OTUs (less than 0.01%), square root transformed and TSS normalised. Significance
of microbiota differences between probiotic and control was calculated using Wilcoxon test
via biomarker discovery function in Calypso [47]. Annotated sequencing dataset used in this
study is publically available on the MG-RAST database under the project number mgp83960
and the library accession number mgl639405.
Ethics statement
This study was approved by the Animal Ethics Committee of Central Queensland University
(A1409-318). The Lactobacillus isolation experiment, including in vivo testing of colonisation
success declared in this manuscript, was approved by the Animal Ethics Committees of RMIT
University (1508). All animal work was conducted in accordance with “The Australian code
for the use of animals for scientific purposes” document.
Results
Colonisation success
There were significant differences in weights of birds between probiotic treated and untreated
birds. The control birds grew faster at the start of the trial and were heavier during the first
week, significantly so between days 2 and 6 (Fig 1A). However, after day 6 there were no sig-
nificant differences between the treatments until day 24, when the probiotic treated birds
exceeded weights of the controls, remaining significantly heavier at 28 days of age, at the time
of the trial termination (Fig 1B).
OTUs corresponding to the three inoculated strains were identified in the sequenced inocu-
lum samples, however, only one of these OTUs, identical to L. ingluvei strain, was able to per-
sist until the end of the experiment while the other two were not detected at any stage of
sampling, including ileal mucosa and caecal samples (Fig 2). There was a contact of inoculum
strains to control birds due to the shared shed environment, despite the wire pens providing
physical separation. This allowed comparing at-hatch large dose inoculation to environmental
Fig 1. Weights of the birds at 4 (A) and 28 days (B). Control PBS inoculated birds were significantly heavier between
the days 2 and 6 post hatch. Between day 6 and 24 there were no significant differences, however, probiotic inoculated
group became significantly heavier starting from day 24 to the end of the trail.
https://doi.org/10.1371/journal.pone.0194825.g001
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colonisation between the two groups. There were significant differences in the abundance of L.
ingluvei OTU across the treatments, however, the only meaningful significant difference, com-
paring the control and probiotic at the same point of sampling, was at 14 days of age when the
inoculated strain was still at a higher level (P = 0.043) than in control in collected excreta sam-
ples. By 28 days, when we additionally sampled caecal content and ileal mucosa, the signifi-
cance between the treatments diminished and inoculated L. ingluvei OTU was noticeably
higher only in probiotic treated illeal mucosa, however, not significantly (P = 0.33). There
were no significant differences in Richness or Evenness index between the probiotic and con-
trol groups although there were differences between the excreta, caecal and mucosal samples
as anticipated.
Multivariate analysis additionally showed significant differences in microbiota structure
between the groups and by both redundancy analysis (RDA, Fig 3) and Adonis statistics on
Weighted Unifrac, P<0.001. We further used Weighted Unifrac and Adonis multivariate sta-
tistics to identify variables influencing the microbiota differences. Based on Adonis, bird sex
had no significance (P = 0.825), while probiotic administration significantly affected micro-
biota (P = 0.037). The different microbiota origins (caecal and ileal mucosa or excreta samples)
likewise had significantly different communities (P = 0.015). This analysis took into account
all sample origins and time points (all 76 sequenced samples as presented in Fig 2). However,
separate analysis was performed for each individual time-point/sample origin matched probi-
otic and control samples (for example excreta control vs excreta probiotic, both 14 days, n = 10
each) where no significant influence of probiotic was detected on individual weekly compari-
sons with smaller sample size.
Changes in excreta microbiota at 14 and 28 days post inoculum
Two weeks after the oral inoculation overall microbiota did not differ significantly between
control and inoculated group (Adonis on Weighted Unirac P = 0.203, n = 10), however
Fig 2. TSS normalised, square root transformed abundance of inoculated L. ingluviei. Out of the 3 OTUs detected
in inoculum, only one, identical to L. ingluviei was detected in birds using sequencing methodology and was present in
all birds across all sampling points. Legend: Pb = probiotic, Ctrl = PBS control.
https://doi.org/10.1371/journal.pone.0194825.g002
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significant changes were detected (Wilcoxon P<0.05) in individual taxa. At the genus level
(Table A in S1 File), the abundance of unclassified Planococcaceae and Clostridiales (Fig 4A)
was increased in the probiotic inoculated birds, while genera Pseudoclavibacter, Nocardiopsis,
Burkholderia and Brevundimonas were detected only in faeces of probiotic inoculated birds.
Lactococcus (Fig 4B) was significantly reduced in the probiotic treated birds. Among the OTUs
there were a number of significantly altered taxa, mostly OTUs belonging to species of the sig-
nificantly affected genera listed above with a high number of clostridia-related OTUs (Fig 5C)
increased in probiotic treated group. Clostridia related species that were most similar to the
clostridial OTUs increased by probiotic were not related to pathogenic “true” Clostridiaceae
clostridia, but aligned with more recently isolated species, some of which are considered bene-
ficial via high short chain acid (SCFA) production. Additionally Enterobacteriaceae OTU,
most similar to Escherichia fergusonii (Fig 4D) and Shigella sonnei (89%) was reduced in abun-
dance in probiotic treated group. The list of genera and OTUs altered at 14 days after at hatch
administration of probiotic with significance levels is given in Tables A and B in S1 File.
Two weeks later, at 28 days of bird’s age, the excreta microbiota was different from the one
at 14 days. This is expected due to microbiota maturation and development changes [37]. The
level of changes according to Weighted Unifrac and ADONIS statistics was comparable in
control (control, 14 vs 28 days; P = 0.002) and in probiotic treated birds (probiotic, 14 vs 28
days; P = 0.002). The differences between the probiotic and control microbial communities at
28 days of age were fewer (Adonis P = 0.841) in excreta samples with only Eubacterium and
Arthrobacter genera different between the treatments (Fig 5A and 5B, Table C in S1 File) and
OTUs with %ID closest to Blautia, Ruminococcus, Alistipes and Bacteroides species (Fig 5C–5F,
Table D in S1 File).
Fig 3. Redundancy analysis (RDA) plot showing group to group microbial community differences between the
treatments, timepoints and sampling origins. Legend: D14 = 14 days, D28 = 28 days, Pb = probiotic, Ctr = PBS
control, C = caecal, M = ileal mucosa.
https://doi.org/10.1371/journal.pone.0194825.g003
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In addition to these two genera also significant in caeca, the caecal community additionally
differed significantly in Brachybacterium, Coprobacillus and Alistipes (Figure A in S1 File,
Tables E and F in S1 File) and ileal mucosa had no overlap with excreta or caecal differences
with increased Weissella and Paracoccus and reduced unclassified Clostridiales in probiotic
treated birds (Figure A in S1 File, Tables G and H in S1 File). Both caecal (P = 0.461) and
ileum (P = 0.445) mucosal microbiotas were not significantly altered between treatments at 28
Fig 4. Phylotypes significantly altered by probiotic administration 14 days post hatch. Complete data with
significance values is provided in Tables A and B in S1 File. Blastn best hits against 16S Microbial database and % ID are
given as a guide.
https://doi.org/10.1371/journal.pone.0194825.g004
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days. However at the OTU level there were some consistent changes noticed. A number of Bac-
teroides uniformis assigned OTUs were significantly increased in probiotic treated birds across
the sampling origins contributing to Bacteroides genus, being highly significantly differential
between the groups (ANOVA P = 3E-12) (Fig 6A). Likewise, an OTU, most similar to Escheri-
chia fergusonii (97%), the most significantly differential OTU in ileum, showed consistency
across the time-points and sampling origins (ANOVA P = 5.8E-7, Fig 6B) as reduced in probi-
otic treated birds.
Discussion
Probiotic strains are highly host specific and often strains isolated from one animal species
cannot colonise other closely related animals [48]. However, strains isolated for human use
Fig 5. Boxplots showing some of the excreta phylotypes altered in abundance by at-hatch probiotic administration 28 days post
hatch. Complete data with significance values is provided in Tables C and D in S1 File. Blastn best hits against 16S Microbial database and
% ID are given as a guide.
https://doi.org/10.1371/journal.pone.0194825.g005
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were often marketed for agricultural animals until recent advances in total microbiota profil-
ing and sequencing technology revealed a wealth of knowledge on microbiota interactions
with the host. Although OTU identical to only one of the 3 inoculated strains 16S amplicon
sequence was detected in experimental birds, it needs to be noted that 16S sequencing based
microbiota profiling studies can detect OTUs present in excreta material higher than 106 cell
per g [49] and that based on changes observed in total microbiota profiles between the control
and probiotic administered group, it is also likely that the inoculated species remained to some
extent in the community, and that deeper sequencing could have determined the degree of
Fig 6. TSS normalised, square root transformed abundance of genus Bacteroides and an OTU most similar (blastn
on 16S Microbial database) to Escherichia fergusonii.
https://doi.org/10.1371/journal.pone.0194825.g006
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success in colonisation. Additionally, it was reported that some strains can help others colonise
without establishing strong presence themselves and also that multi-strain probiotics are gen-
erally more efficient than single strains they are comprised of [50] although strains could not
colonise with the same success.
Our data show that there are clear differences between probiotic-inoculated and control
birds with effects often reproducible even between physiologically different gut sampling ori-
gins (Fig 6). While the presence of the best colonising inoculated strain was higher in earlier
days reducing by day 28, the probiotic inoculation had lasting effects on the development of
the community rather than establishing dominance.
Comparable phylotypes were altered in the probiotic inoculated group in both excreta and
caecal samples as expected [51]. These changes in the probiotic group consisted of reduction
in Alistipes and Ruminococcus related species. Not much is known about the roles of Alistipes,
while Ruminococcus are generally considered as beneficial bacteria. However, most of the
Ruminococcus–annotated OTUs were also highly similar with Clostridium species from Rumi-
nococcaceae family, these are often difficult to resolve with 16S based taxonomy and may
require additional identification. Probiotic treatment also increased Bacteroides uniformis spe-
cies, (some OTUs were 100% identical in sequence across the amplified region), in both
excreta and caecal samples. Some of these OTUs were completely absent from control faeces
and caeca. Bacteroides uniformis is known to have the potential to degrade the isoflavones in
the gut [52], and significantly improve metabolic and immunological dysfunction in mice with
diet induced obesity [53]. However, some antibiotic resistant strains may have pathogenic
potential [54]. There was also an indication that at-hatch inoculation of L. ingluvei was able to
reduce Shigella / Escherichia related OTUs. These two genera cannot be resolved using partial
16S amplicons. It was previously reported that Lactobacillus acidophilus was able to inhibit
growth of Escherichia coli in chickens [55]. However, in our data, this inhibition was not
detected during classic ongoing probiotic administration but instead, it was confirmed 28 days
post single probiotic dose inoculation. Total removal or depletion of Escherichia or other
enterobacteria from intestinal mucosa may have clinical significance.
Another promising outcome was an increase of Weissella species in mucosal bacterial com-
munities. We have previously reported the depletion of Weissella confusa is associated with
necrotic enteritis in chicken [56]. Weissella confusa is a heterofermentative lactic acid bacteria,
previously classified as Lactobacillus [57], used in traditional fermentations [58], and is also
used as probiotic [59, 60]. More in vitro and in vivo investigations are needed to validate the
ability of these strains to stimulate Weissella and other mucosa protective species as probiotics
are often associated with repair of gut mucosal disruptions such as diarrhoea [61].
Conclusions
The results indicate that early inoculation of probiotic strains can influence intestinal micro-
biota and has the potential to improve weight gain via microbiota modifications. Our data con-
firm the clear difference between at-hatch administration of beneficial strain compared to the
natural acquisition of the same strain from the environment. The way of inoculum preparation
(fresh, exponentially growing vs freeze-dried cells for example), chicken breed and shed/farm
resident microbiota are all expected to play a role in the outcome of probiotic treatment and
should be further investigated.
Supporting information
S1 File. This file contains Figure A and Tables A-H.
(PDF)
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